Sanne van Wissen
About
Sanne van Wissen is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Immunology.
According to data from OpenAlex, Sanne van Wissen has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Immunology. Recurrent topics in Sanne van Wissen's work include Lipoproteins and Cardiovascular Health (16 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Sanne van Wissen is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Sanne van Wissen collaborates with scholars based in Netherlands, United States and Italy. Sanne van Wissen's co-authors include TJ Smilde, M van Linde-Sibenius Trip, A.F.H. Stalenhoef, John J.P. Kastelein, Tineke J. Smilde, Anton F. H. Stalenhoef, Mieke D. Trip, Jacqueline de Graaf, Angelique C.M. Jansen and Joep C. Defesche and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The American Journal of Cardiology.
In The Last Decade
Sanne van Wissen
24 papers receiving 1.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sanne van Wissen Netherlands | 15 | 934 | 441 | 403 | 271 | 256 | 24 | 1.4k | ||
| Nitin Mahajan United States | 18 | 580 0.6× | 389 0.9× | 311 0.8× | 170 0.6× | 193 0.8× | 66 | 1.5k | ||
| М. В. Ежов Russia | 17 | 1.3k 1.4× | 648 1.5× | 431 1.1× | 350 1.3× | 261 1.0× | 154 | 1.8k | ||
| Brad Bisson United States | 7 | 1.3k 1.4× | 562 1.3× | 675 1.7× | 229 0.8× | 147 0.6× | 9 | 1.8k | ||
| Anja Vogt Germany | 19 | 1.1k 1.2× | 397 0.9× | 353 0.9× | 234 0.9× | 152 0.6× | 66 | 1.5k | ||
| M van Linde-Sibenius Trip Netherlands | 8 | 706 0.8× | 401 0.9× | 480 1.2× | 216 0.8× | 92 0.4× | 8 | 1.2k | ||
| Lulu Ren Sterling United States | 16 | 961 1.0× | 419 1.0× | 368 0.9× | 247 0.9× | 136 0.5× | 21 | 2.2k | ||
| Patrick M. Moriarty United States | 18 | 1.3k 1.4× | 394 0.9× | 349 0.9× | 282 1.0× | 190 0.7× | 40 | 1.7k | ||
| Greg Brown United States | 3 | 1.3k 1.4× | 573 1.3× | 755 1.9× | 264 1.0× | 143 0.6× | 3 | 1.8k | ||
| Sander I. van Leuven Netherlands | 20 | 683 0.7× | 449 1.0× | 448 1.1× | 190 0.7× | 458 1.8× | 45 | 1.8k | ||
| Christopher E. Kurtz United States | 19 | 1.3k 1.4× | 617 1.4× | 360 0.9× | 207 0.8× | 167 0.7× | 39 | 1.8k |
Countries citing papers authored by Sanne van Wissen
Since
Specialization
Citations
This map shows the geographic impact of Sanne van Wissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanne van Wissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanne van Wissen more than expected).
Fields of papers citing papers by Sanne van Wissen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sanne van Wissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanne van Wissen. The network helps show where Sanne van Wissen may publish in the future.
Co-authorship network of co-authors of Sanne van Wissen
This figure shows the co-authorship network connecting the top 25 collaborators of Sanne van Wissen. A scholar is included among the top collaborators of Sanne van Wissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanne van Wissen. Sanne van Wissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hamulyák, Eva N., Hanke M.G. Wiegers, Luuk J.J. Scheres, et al.. (2020). Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study. Research and Practice in Thrombosis and Haemostasis. 5(1). 223–230.
2.
Cate‐Hoek, Arina J. ten, A.C. Bouman, Karina Meijer, et al.. (2018). Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis. The Lancet Haematology. 5(11). e512–e519.
3.
Joore, Manuela, Hugo Ten Cate, Karina Meijer, et al.. (2018). Clinical and economic impact of compression in the acute phase of deep vein thrombosis. Journal of Thrombosis and Haemostasis. 16(8). 1555–1563.
4.
Meuwese, Marijn C., et al.. (2007). Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia. Atherosclerosis. 197(2). 916–921.
5.
Wissen, Sanne van, Tineke J. Smilde, Mieke D. Trip, Anton F. H. Stalenhoef, & John J.P. Kastelein. (2005). Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. The American Journal of Cardiology. 95(2). 264–266.
6.
Tits, Lambertus J.H. van, Tineke J. Smilde, Sanne van Wissen, et al.. (2004). Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subtraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia. Journal of Investigative Medicine. 52(3). 177–184.
7.
Netea, Mihai G., Anneke Hijmans, Sanne van Wissen, et al.. (2004). Toll‐like receptor‐4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. European Journal of Clinical Investigation. 34(2). 94–99.
8.
Grooth, Greetje J. de, Tineke J. Smilde, Sanne van Wissen, et al.. (2004). The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. Atherosclerosis. 173(2). 261–267.
9.
Tits, Lambertus J.H. van, Tineke J. Smilde, Sanne van Wissen, et al.. (2004). Effects of Atorvastatin and Simvastatin on Low-Density Lipoprotein Subfraction Profile, Low-Density Lipoprotein Oxidizability, and Antibodies to Oxidized Low-Density Lipoprotein in Relation to Carotid Intima Media Thickness in Familial Hypercholesterolemia. Journal of Investigative Medicine. 52(3). 177–177.
10.
Wissen, Sanne van, Tineke J. Smilde, Eric de Groot, et al.. (2003). The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study. European Journal of Cardiovascular Prevention & Rehabilitation. 10(6). 451–455.
11.
Wissen, Sanne van, et al.. (2003). Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. Heart. 89(8). 893–896.
12.
Semb, Anne Grete, Sanne van Wissen, Thor Ueland, et al.. (2003). Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. Journal of the American College of Cardiology. 41(2). 275–279.
13.
Trip, Mieke D., Sanne van Wissen, Tineke J. Smilde, et al.. (2003). Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia. The American Journal of Cardiology. 91(5). 604–606.
14.
Jansen, Angelique C.M., Sanne van Wissen, Joep C. Defesche, & John J.P. Kastelein. (2002). Phenotypic variability in familial hypercholesterolaemia: an update. Current Opinion in Lipidology. 13(2). 165–171.
15.
Dam, Marjel van, Sanne van Wissen, & J.J.P. Kastelein. (2002). Declaring War on Undertreatment: Rationale for an Aggressive Approach to Lowering Cholesterol. European Journal of Cardiovascular Prevention & Rehabilitation. 9(2). 89–95.
16.
Dam, Marjel van, Sanne van Wissen, & John J.P. Kastelein. (2002). Declaring war on undertreatment: rationale for an aggressive approach to lowering cholesterol. Journal of Cardiovascular Risk. 9(2). 89–95.
17.
Wissen, Sanne van, Mieke D. Trip, Tineke J. Smilde, et al.. (2002). Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. Atherosclerosis. 165(2). 361–366.
18.
Smilde, TJ, et al.. (2001). Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial. The Lancet. 357(9256). 577–581.
19.
Smilde, Tineke J., et al.. (2001). Measurement of atherosclerosis progression. The Lancet. 358(9278). 329–329.
20.
Smilde, Tineke J., Mieke D. Trip, Hub Wollersheim, et al.. (2000). Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia. Clinical Drug Investigation. 20(2). 67–79.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nitin Mahajan Breakdown of academic impact, for papers by М. В. Ежов Breakdown of academic impact, for papers by Brad Bisson Breakdown of academic impact, for papers by Anja Vogt Breakdown of academic impact, for papers by M van Linde-Sibenius Trip Breakdown of academic impact, for papers by Lulu Ren Sterling Breakdown of academic impact, for papers by Patrick M. Moriarty Breakdown of academic impact, for papers by Greg Brown Breakdown of academic impact, for papers by Sander I. van Leuven Breakdown of academic impact, for papers by Christopher E. Kurtz